This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/Methylphenidate: Difference between revisions
Jump to navigation
Jump to search
>Miceneme personal experience and reading through erowid experience reports, euphoria/peak only persists for ~45 mins max and then fades into residual stimulation, the nasty side effects associated with methylphenidate kick in right after the peak as well |
>MeyveliPasta Added bioavailability for oral |
||
| Line 69: | Line 69: | ||
|OralROA_Collapsed=false | |OralROA_Collapsed=false | ||
|OralROA_Caption= | |OralROA_Caption= | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability=11-52%<ref name="Health Canada - Ritalin">"https://s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/483/original/Health_Canada_-_Ritalin.PDF?1556050208"</ref> | ||
|OralROA_Threshold=[[Oral threshold dose::5]] [[Oral dose units::mg]] | |OralROA_Threshold=[[Oral threshold dose::5]] [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral min light dose::10]] - [[Oral max light dose::20]] mg | |OralROA_Light=[[Oral min light dose::10]] - [[Oral max light dose::20]] mg | ||
Revision as of 19:45, 22 August 2020
| SubstanceBox/Methylphenidate | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Chemical Nomenclature | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common names | Methylphenidate, Concerta, Methylin, Ritalin, Equasym XL | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Substitutive name | Methylphenidate | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Systematic name | Methyl 2-phenyl-2-piperidin-2-ylacetate | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Class Membership | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Psychoactive class | Stimulant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Chemical class | Phenidate | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Routes of Administration | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||